Momenta Pharmaceuticals, Inc. (MNTA)

[DewDiligence]

Update on $100M Lovenox bond:

AMPH expects a final order from the US District Court “any day” to take possession of the $100M bond put up by NVS/MNTA in the Loveniox patent case, according to AMPH’s 4Q17 CC.

MNTA is responsible for $35M (35%) of the $100M bond liability, and MNTA has already earmarked half of that amount ($17.5M) as “restricted” cash, which is effectively a reserve. So the balance-sheet impact on MNTA from forfeiture of the bond will be an additional $17.5M deduction from the “regular” cash line on the balance sheet.